bluebird bio
BLUE
#9803
Rank
$48.66 M
Marketcap
$4.97
Share price
0.00%
Change (1 day)
-75.64%
Change (1 year)

Operating Margin for bluebird bio (BLUE)

Operating Margin as of December 2025 (TTM): -192.22%

According to bluebird bio 's latest financial reports and stock price the company's current Operating Margin is -192.22%. At the end of 2024 the company had an Operating Margin of -260.20%.

Operating Margin history for bluebird bio from 2012 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
2024-260.20%-60.78%
2023-663.41%-89.34%
2022-6,224.72%-59.66%
2021-15,431.73%
2018-1,042.57%11.02%
2017-939.09%-78.08%
2016-4,284.96%263.05%
2015-1,180.25%396.91%
2014-237.52%92.14%
2013-123.62%-98.23%
2012-6,975.29%306.3%
2011-1,716.78%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
BioMarin Pharmaceutical
BMRN
21.95%-111.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-226.57% 17.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
15.12%-107.87%๐Ÿ‡ซ๐Ÿ‡ท France
Sangamo Therapeutics
SGMO
-169.73%-11.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
31.06%-116.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-30,182.40% 15,602.01%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.